Manufacturer
PFIZER MANUFACTURING BELGIUM NV,
Contents
Meningococcal polysaccharide serogroups A, C, W-135 & Y conjugate vaccine
Indication
Active immunization against invasive meningococcal diseases caused by N meningitidis serogroups A, C, W-135 & Y in individuals ≥12 mth.
Instruction
For IM injection only, preferably in the deltoid muscle. In children 12-23 months, Nimenrix may also be administered in the anterolateral part of the thigh (see Precautions and Interactions).
Drug interaction
Adequate response may not be elicited w/ immunosuppressants.
Malaysia
